Prophylactic anticoagulants for people hospitalised with COVID‐19

Review of 7 studies (n=5929) concludes there is insufficient evidence to determine risks and benefits of prophylactic anticoagulants for people hospitalised with COVID‐19. There are 22 studies in >15,000 participants underway however,which will provide more robust evidence.

Cochrane Database of Systematic Reviews